Cetadiol

Cetadiol, also known as androst-5-ene-3β,16α-diol, is a drug described as a "steroid tranquilizer" which was briefly investigated as a treatment for alcoholism in the 1950s.[1][2][3][4][5] It is an androstane steroid and analogue of 5-androstenediol (androst-5-ene-3β,17β-diol) and 16α-hydroxy-DHEA (androst-5-ene-3β,16α-diol-17-one), but showed no androgenic or myotrophic activity in animal bioassays.[4] The drug was reported in 1956 and studied until 1958.[1]

Cetadiol
Clinical data
Other namesAndrost-5-ene-3β,16α-diol; 3β,16α-Dihydroxy-5-androstene
Routes of
administration
Oral
Identifiers
CAS Number
PubChem CID
ChemSpider
KEGG
ChEBI
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC19H30O2
Molar mass290.447 g·mol−1
3D model (JSmol)

Chemistry

See also

References

  1. J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 86–. ISBN 978-1-4757-2085-3.
  2. Martin Negwer; Hans-Georg Scharnow (2001). Organic-chemical drugs and their synonyms: (an international survey). Wiley-VCH. p. 1841. ISBN 978-3-527-30247-5.
  3. LEMERE F (1957). "New steroid hormone tranquilizing agent (cetadiol)". Am J Psychiatry. 113 (10): 930. doi:10.1176/ajp.113.10.930. PMID 13402989.
  4. CAMPBELL CH, SLEEPER HG (1956). "Cetadiol (5-androstene-3 16-diol) in the treatment of hospitalized alcoholics". Am J Psychiatry. 112 (10): 845. doi:10.1176/ajp.112.10.845. PMID 13302491.
  5. WEXLER D, LEIDERMAN PH, MENDELSON J, KUBZANSKY P, SOLOMON P (1958). "The effect of cetadiol on delirium tremens, alcoholic hallucinosis, and alcohol withdrawal". Am J Psychiatry. 114 (10): 935–6. doi:10.1176/ajp.114.10.935. PMID 13508929.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.